SCHEMBL19367143

SCHEMBL19367143

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccccc3-c3ccc4sc5ccc(-c6ccccc6-c6nc(-c7ccccc7)cc(-c7ccccc7)n6)cc5c4c3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.44
KMT2A Q03164 9/20 0.44
MAPT P10636 7/20 0.44
ALDH1A1 P00352 5/20 0.44
HPGD P15428 5/20 0.44
NTSR1 P30989 1/20 0.44
TDP1 Q9NUW8 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
PIM3 Q86V86 1/20 0.39
LMNA P02545 3/20 0.39
KDM4E B2RXH2 3/20 0.39
GLA P06280 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPK10 P53779 1/20 0.39
ROCK1 Q13464 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19367142 0.93 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22700735 0.89 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22700633 0.89 MEN1 (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL15501586 0.87 PIM3 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL15501385 0.87 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25097977 0.86 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL15501696 0.86 PIM3 (0.42) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19165527 0.86 ALDH1A1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22700574 0.86 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL9920514 0.85 MEN1 (0.56) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295490-A1 LIGHT-EMITTING NANOPARTICLES AND LIGHT-EMITTING LABELING MATERIAL FOR PATHOLOGICAL DIAGNOSIS Konica Minolta, Inc. (JP) 2023-09-21 US disclosed
US-20230295490-A1 LIGHT-EMITTING NANOPARTICLES AND LIGHT-EMITTING LABELING MATERIAL FOR PATHOLOGICAL DIAGNOSIS Konica Minolta, Inc. (JP) 2023-09-21 US disclosed
US-11329234-B2 Organic electroluminescent element, display device, lighting device, π-conjugated compound, and light-emitting thin film MERCK PATENT GMBH (DE) 2022-05-10 US disclosed
WO-2021261398-A1 LIGHT-EMITTING NANOPARTICLES AND LIGHT-EMITTING LABELING MATERIAL FOR PATHOLOGICAL DIAGNOSIS コニカミノルタ株式会社 2021-12-30 WO disclosed
US-10950799-B2 Organic electroluminescent element, display device, lighting device, PI-conjugated compound, and light-emitting thin film MERCK PATENT GMBH (DE) 2021-03-16 US disclosed
US-20200044164-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM UDC IRELAND LIMITED (IE) 2020-02-06 US disclosed
US-20170271597-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM MERCK PATENT GMBH (DE) 2017-09-21 US disclosed
US-20170271597-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM MERCK PATENT GMBH (DE) 2017-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044164-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM LPO, L1CAM, INTS9 MEN1 4681/4885KMT2A 3679/4885MAPT 589/4885
US-10950799-B2 Organic electroluminescent element, display device, lighting device, PI-conjugated compound, and light-emitting thin film LPO, L1CAM, INTS9 MEN1 4681/4885KMT2A 3679/4885MAPT 589/4885
US-20170271597-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, LIGHTING DEVICE, PI-CONJUGATED COMPOUND, AND LIGHT-EMITTING THIN FILM LPO, L1CAM, INTS9 MEN1 4634/4885KMT2A 3686/4885MAPT 627/4885
US-11329234-B2 Organic electroluminescent element, display device, lighting device, π-conjugated compound, and light-emitting thin film LPO, L1CAM, SELE MEN1 4528/4885KMT2A 3451/4885MAPT 444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.